Page last updated: 2024-11-06

prednisolone and Hypokalemic Periodic Paralysis

prednisolone has been researched along with Hypokalemic Periodic Paralysis in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Hypokalemic Periodic Paralysis: An autosomal dominant familial disorder characterized by recurrent episodes of skeletal muscle weakness associated with falls in serum potassium levels. The condition usually presents in the first or second decade of life with attacks of trunk and leg paresis during sleep or shortly after awakening. Symptoms may persist for hours to days and generally are precipitated by exercise or a meal high in carbohydrates. (Adams et al., Principles of Neurology, 6th ed, p1483)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agrawal, S1
Bharti, V1
Jain, MN1
Purkar, PD1
Verma, A1
Deshpande, AK1

Other Studies

1 other study available for prednisolone and Hypokalemic Periodic Paralysis

ArticleYear
Sjogren's syndrome presenting with hypokalemic periodic paralysis.
    The Journal of the Association of Physicians of India, 2012, Volume: 60

    Topics: Acidosis, Renal Tubular; Administration, Intravenous; Adult; Antibodies, Antinuclear; Female; Glucoc

2012